Tianju Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tianju Wang has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Jun Qi
HLA Laboratory, Shaanxi Province Blood Center Institute of Xi'an Blood Bank Xi'an Shaanxi Province China
7 shared publications - Li Pinf Chen
School of Environment and Energy, South China University of Technology, Guangzhou, 510006, China
4 shared publications - Hengxin Li
Xi'an Center for Disease Control and Prevention, Xi'an, China
3 shared publications - Sheng Liu
Blood Center of the Shaanxi Province, Xi'an, Shaanxi, People's Republic of China
3 shared publications - Chun-Mei Shen
Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications Jun Qi
2 shared publications
Latest Publications
- 13 November 2024
- Published by Wiley in British Journal of Haematology
- Vol. 206 (2) , 735-748
Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia
Summary: Human leucocyte antigen (HLA) class II molecules are critically involved in the pathology of acquired aplastic anaemia (AA) by regulating the immune response and autoreactive T cell‐mediated haematopoietic cell death. In the study, amino acid residue variation and molecular structure of HLA class II have been initially investigated in 96 patients with AA. The frequencies of residues 9 and 57 in pocket 9 (P9) in DQB1, and amino acid positions 9, 11, 13, 16, 26, 38, 67 and 71 in the P4, P6 and P9 pockets in DRB1 were more prevalent among AA patients. By applying a multivariate recursive approach, the DRβ‐Gln‐16 (OR = 3.003, 95% CI = 1.468–6.145, pc = 0.003), DRβ‐Ala‐71 (OR = 1.924, 95% CI = 1.233–3.002, pc = 0.004) in P4/P7 and DQβ‐Asp‐57 (OR = 3.483, 95% CI = 1.079–11.242, pc = 0.037) in P9, these critical residues were significantly discovered as risk amino acid residues on the onset of AA, as well as associated with PNH‐type cells and pathological somatic or cytogenetic mutations. In silico structural model analysis showed that identified DRβ‐Ala‐71 and DQβ‐Asp‐57 within the antigen‐binding groove interacting with a more variable antigenic segments, may impact the repertoire of peptides presented, influence the interface HLA‐antigen‐T‐cell receptor β (TCR β). These findings provided light on the immunogenetic pathophysiology of AA aetiology and their potential impact on upcoming immunotherapies.
- 13 November 2024
- Published by Wiley in British Journal of Haematology
- Vol. 206 (2) , 735-748
Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia
Summary: Human leucocyte antigen (HLA) class II molecules are critically involved in the pathology of acquired aplastic anaemia (AA) by regulating the immune response and autoreactive T cell‐mediated haematopoietic cell death. In the study, amino acid residue variation and molecular structure of HLA class II have been initially investigated in 96 patients with AA. The frequencies of residues 9 and 57 in pocket 9 (P9) in DQB1, and amino acid positions 9, 11, 13, 16, 26, 38, 67 and 71 in the P4, P6 and P9 pockets in DRB1 were more prevalent among AA patients. By applying a multivariate recursive approach, the DRβ‐Gln‐16 (OR = 3.003, 95% CI = 1.468–6.145, pc = 0.003), DRβ‐Ala‐71 (OR = 1.924, 95% CI = 1.233–3.002, pc = 0.004) in P4/P7 and DQβ‐Asp‐57 (OR = 3.483, 95% CI = 1.079–11.242, pc = 0.037) in P9, these critical residues were significantly discovered as risk amino acid residues on the onset of AA, as well as associated with PNH‐type cells and pathological somatic or cytogenetic mutations. In silico structural model analysis showed that identified DRβ‐Ala‐71 and DQβ‐Asp‐57 within the antigen‐binding groove interacting with a more variable antigenic segments, may impact the repertoire of peptides presented, influence the interface HLA‐antigen‐T‐cell receptor β (TCR β). These findings provided light on the immunogenetic pathophysiology of AA aetiology and their potential impact on upcoming immunotherapies.
- 17 August 2023
- Published by Springer Nature in Immunogenetics
- Vol. 75 (5) , 1-10
Correlation between human leukocyte antigen ligands and killer cell immunoglobulin-like receptors in aplastic anemia patients from Shaanxi Han
Regulating natural killer (NK) cell responses in hematological malignancies largely depend on molecular interactions between killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen (HLA) class I ligands. The goal of the current study was to examine the key functions of KIR genes, gene combinations of KIR-HLA, and KIR genotypes in genetic predisposition to aplastic anemia (AA). Herein, the genotyping of 16 KIR genes and HLA-A, -B, and -C ligands were performed in 72 AA patients and 150 healthy controls using PCR evaluations with sequence-specific primers using standard assays. According to the obtained results, AA patients had an increased incidence of activating KIR and KIR2DS4 (P = 0.465 × 10−4, Pc = 0.837 × 10−3, OR = 20.81, 95% CI = 2.786–155.5) compared to controls. KIR/HLA class I ligand profile KIR2DS4/C1 (P = 0.350 × 10−4, Pc = 0.630 × 10−3, OR = 8.944, 95% CI = 2.667–29.993) was significantly elevated in AA patients compared to healthy controls. Genotype AA1 (P = 0.003, OR = 2.351, 95% CI = 1.325–4.172) were increased, and AA195 (P = 0.006, OR = 0.060, 95% CI = 0.004–1.023) was decreased among AA cases compared to controls. Our findings indicated that KIR2DS4 may play a role in the pathogenesis of AA. This study revealed the contribution of KIR genes in the etiology of AA cases.
- 17 August 2023
- Published by Springer Nature in Immunogenetics
- Vol. 75 (5) , 1-10
Correlation between human leukocyte antigen ligands and killer cell immunoglobulin-like receptors in aplastic anemia patients from Shaanxi Han
Regulating natural killer (NK) cell responses in hematological malignancies largely depend on molecular interactions between killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen (HLA) class I ligands. The goal of the current study was to examine the key functions of KIR genes, gene combinations of KIR-HLA, and KIR genotypes in genetic predisposition to aplastic anemia (AA). Herein, the genotyping of 16 KIR genes and HLA-A, -B, and -C ligands were performed in 72 AA patients and 150 healthy controls using PCR evaluations with sequence-specific primers using standard assays. According to the obtained results, AA patients had an increased incidence of activating KIR and KIR2DS4 (P = 0.465 × 10−4, Pc = 0.837 × 10−3, OR = 20.81, 95% CI = 2.786–155.5) compared to controls. KIR/HLA class I ligand profile KIR2DS4/C1 (P = 0.350 × 10−4, Pc = 0.630 × 10−3, OR = 8.944, 95% CI = 2.667–29.993) was significantly elevated in AA patients compared to healthy controls. Genotype AA1 (P = 0.003, OR = 2.351, 95% CI = 1.325–4.172) were increased, and AA195 (P = 0.006, OR = 0.060, 95% CI = 0.004–1.023) was decreased among AA cases compared to controls. Our findings indicated that KIR2DS4 may play a role in the pathogenesis of AA. This study revealed the contribution of KIR genes in the etiology of AA cases.
- Open Access
- 27 February 2023
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (4)
Haplotype‐dependent HLA‐DRB1‐DQB1 susceptibility to occult HBV infection in Xi'an Han population
Background: Occult hepatitis B virus (HBV) infection (OBI) is primarily characterized by the persistence of HBV‐DNA in the liver tissues and/or in the serum without detectable HBsAg. Human leukocyte antigen (HLA) polymorphisms have been found to be strongly associated with HBV in different ethnic backgrounds. The association of HLA‐DRB1‐DQB1 haplotypes with OBI has not been previously reported in China. The aim of this study was to identify the potential association of HLA‐DRB1‐DQB1 haplotypes that may be involved in OBI genetic susceptibility.Methods: A case–control study was conducted between 107 OBI subjects and 280 healthy controls from the blood donors in the Shaanxi Province Blood Center. The HLA‐DRB1, DQB1 loci were genotyped using polymerase chain reaction‐sequence based typing (PCR‐SBT). Based on the genotype data of the two loci, haplotype estimation was performed.Results: HLA‐DRB1*07:01‐DQB1*02:02 (pc = 0.344 × 10−3, OR = 3.489, 95%CI = 2.000–6.088) and HLA‐DRB1*09:01‐DQB1*03:03 (pc = 0.02, OR = 2.370, 95%CI = 1.450–3.873) serve as the possible risk and susceptibility haplotypes for OBI in Xi'an Han after Bonferroni correction.Conclusions: This study demonstrated that HLA II haplotypes were significantly associated with OBI in the Xi'an Han population. To the best of our knowledge, this is the first study to associate HLA‐DRB1‐DQB1 haplotypes with OBI, which can provide valuable insights into the relationship between the various genetic factors and immune responses in the Xi'an population. The findings can also form the basis for future studies about the role of HLA in OBI.
- 27 February 2023
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (4)
Open AccessHaplotype‐dependent HLA‐DRB1‐DQB1 susceptibility to occult HBV infection in Xi'an Han population
Background: Occult hepatitis B virus (HBV) infection (OBI) is primarily characterized by the persistence of HBV‐DNA in the liver tissues and/or in the serum without detectable HBsAg. Human leukocyte antigen (HLA) polymorphisms have been found to be strongly associated with HBV in different ethnic backgrounds. The association of HLA‐DRB1‐DQB1 haplotypes with OBI has not been previously reported in China. The aim of this study was to identify the potential association of HLA‐DRB1‐DQB1 haplotypes that may be involved in OBI genetic susceptibility.Methods: A case–control study was conducted between 107 OBI subjects and 280 healthy controls from the blood donors in the Shaanxi Province Blood Center. The HLA‐DRB1, DQB1 loci were genotyped using polymerase chain reaction‐sequence based typing (PCR‐SBT). Based on the genotype data of the two loci, haplotype estimation was performed.Results: HLA‐DRB1*07:01‐DQB1*02:02 (pc = 0.344 × 10−3, OR = 3.489, 95%CI = 2.000–6.088) and HLA‐DRB1*09:01‐DQB1*03:03 (pc = 0.02, OR = 2.370, 95%CI = 1.450–3.873) serve as the possible risk and susceptibility haplotypes for OBI in Xi'an Han after Bonferroni correction.Conclusions: This study demonstrated that HLA II haplotypes were significantly associated with OBI in the Xi'an Han population. To the best of our knowledge, this is the first study to associate HLA‐DRB1‐DQB1 haplotypes with OBI, which can provide valuable insights into the relationship between the various genetic factors and immune responses in the Xi'an population. The findings can also form the basis for future studies about the role of HLA in OBI.
- Open Access
- 25 April 2022
- Published by Springer Nature in BMC Immunology
- Vol. 23 (1) , 1-12
High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection
Aim: To investigate the association of human leukocyte antigen (HLA)-DRB1 alleles and the variations of polymorphic amino acid changes in DRβ1 chain in Shaanxi Han population with Occult hepatitis B infection (OBI). Methods: High-resolution HLA-DRB1 genotyping was performed in 107 OBI carriers and 280 normal controls. Sequence information was used to assign which amino acids were encoded at all polymorphic positions. Three-dimensional modeling was performed to explore the effect of the key residues on the HLA-DRB1 molecule. Results: Strong susceptible association for allele DRB1*07:01 was observed in OBI carriers. The amino acid variation at HLA-DRβ1 molecule revealed susceptible associations for residues Gln4β, Val57β(P9), Ser60β(P9) and Val78β(P4), the amino acids Arg4β, Asp57β(P9), Tyr60β(P9) and Tyr78β(P4) showed protective associations. Conclusion: Alleles DRB1*07:01 showed strong susceptible associations in OBI carriers. The amino acid variations in DRβ molecules revealed significant molecular markers for susceptibility and protection from OBI in Shaanxi Han population.
- 25 April 2022
- Published by Springer Nature in BMC Immunology
- Vol. 23 (1) , 1-12
Open AccessHigh resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection
Aim: To investigate the association of human leukocyte antigen (HLA)-DRB1 alleles and the variations of polymorphic amino acid changes in DRβ1 chain in Shaanxi Han population with Occult hepatitis B infection (OBI). Methods: High-resolution HLA-DRB1 genotyping was performed in 107 OBI carriers and 280 normal controls. Sequence information was used to assign which amino acids were encoded at all polymorphic positions. Three-dimensional modeling was performed to explore the effect of the key residues on the HLA-DRB1 molecule. Results: Strong susceptible association for allele DRB1*07:01 was observed in OBI carriers. The amino acid variation at HLA-DRβ1 molecule revealed susceptible associations for residues Gln4β, Val57β(P9), Ser60β(P9) and Val78β(P4), the amino acids Arg4β, Asp57β(P9), Tyr60β(P9) and Tyr78β(P4) showed protective associations. Conclusion: Alleles DRB1*07:01 showed strong susceptible associations in OBI carriers. The amino acid variations in DRβ molecules revealed significant molecular markers for susceptibility and protection from OBI in Shaanxi Han population.
- 13 October 2021
- Published by Wiley in The Journal of Gene Medicine
- Vol. 24 (1) , e3393
Human leukocyte antigen class I association with occult hepatitis B virus infection in the Shaanxi Han group: Analysis at the haplotype level
Background: Human leucocyte antigen (HLA) class I genes and haplotypes correlate with hepatitis B virus (HBV) infection. Occult HBV infection (OBI), a special type of chronic HBV infection, is defined as HBV surface antigen negative patients with or those without serologic markers by the means of HBV DNA detection in human plasma or in liver tissue by a diagnostic test. So far, the associations of HLA I haplotypes with OBI have not been reported previously in China.Methods: A case–control study between 107 OBI subjects and 280 healthy controls from blood donors in the Blood Center of the Shaanxi Province was conducted in the present association analysis. The HLA‐A, ‐B and ‐C loci of case–control subjects were detected and genotyped by polymerase chain reaction‐sequence based typing. The HLA‐A, ‐B and ‐C haplotypic frequencies were calculated by the maximum likelihood method.Results: The HLA‐A*33:03‐C*07:01G (pc = 0.039, odds ratio [OR] = 8.996, 95% confidence interval [CI] = 1.825–44.338), B*44:03‐C*07:01G (pc = 0.0069, OR = 12.000, 95% CI = 2.507–57.436) and A*33:03‐B*44:03‐C*07:01G (pc = 0.04, OR = 7.094, 95% CI = 1.387–36.288) haplotypes showed a a significant positive association with OBI. Independent effects demonstrated that HLA‐B*44:03 and HLA‐C*07:01G gave the main contribution to risk, whereas HLA‐A*33:03 was associated only by linkage disequilibrium.Conclusions: This present study is the first to demonstrate that HLA I haplotypes are associated with OBI in the Shaanxi Han population. The present results suggest that HLA‐B*44:03‐C*07:01G might be a potential risk factor for OBI.Comparisons of the frequencies of HLA I haplotypes at high resolution were made between OBI from northern Chinese Han and controls. Frequencies of HLA‐A‐B, A‐C, B‐C, A‐B‐C between the OBI group (gray column) and the control group (blank column) were compared. Haplotypes with p < 0.05 in either group were shown. p values for multiple comparisons (pc) were corrected by Bonferroni correction (*pc < 0.05).
- 13 October 2021
- Published by Wiley in The Journal of Gene Medicine
- Vol. 24 (1) , e3393
Human leukocyte antigen class I association with occult hepatitis B virus infection in the Shaanxi Han group: Analysis at the haplotype level
Background: Human leucocyte antigen (HLA) class I genes and haplotypes correlate with hepatitis B virus (HBV) infection. Occult HBV infection (OBI), a special type of chronic HBV infection, is defined as HBV surface antigen negative patients with or those without serologic markers by the means of HBV DNA detection in human plasma or in liver tissue by a diagnostic test. So far, the associations of HLA I haplotypes with OBI have not been reported previously in China.Methods: A case–control study between 107 OBI subjects and 280 healthy controls from blood donors in the Blood Center of the Shaanxi Province was conducted in the present association analysis. The HLA‐A, ‐B and ‐C loci of case–control subjects were detected and genotyped by polymerase chain reaction‐sequence based typing. The HLA‐A, ‐B and ‐C haplotypic frequencies were calculated by the maximum likelihood method.Results: The HLA‐A*33:03‐C*07:01G (pc = 0.039, odds ratio [OR] = 8.996, 95% confidence interval [CI] = 1.825–44.338), B*44:03‐C*07:01G (pc = 0.0069, OR = 12.000, 95% CI = 2.507–57.436) and A*33:03‐B*44:03‐C*07:01G (pc = 0.04, OR = 7.094, 95% CI = 1.387–36.288) haplotypes showed a a significant positive association with OBI. Independent effects demonstrated that HLA‐B*44:03 and HLA‐C*07:01G gave the main contribution to risk, whereas HLA‐A*33:03 was associated only by linkage disequilibrium.Conclusions: This present study is the first to demonstrate that HLA I haplotypes are associated with OBI in the Shaanxi Han population. The present results suggest that HLA‐B*44:03‐C*07:01G might be a potential risk factor for OBI.Comparisons of the frequencies of HLA I haplotypes at high resolution were made between OBI from northern Chinese Han and controls. Frequencies of HLA‐A‐B, A‐C, B‐C, A‐B‐C between the OBI group (gray column) and the control group (blank column) were compared. Haplotypes with p < 0.05 in either group were shown. p values for multiple comparisons (pc) were corrected by Bonferroni correction (*pc < 0.05).
Identification of a novel allele HLA‐C*03:560N by next‐generation sequencing in a hematopoietic stem cell recipient
A frameshift because of a single nucleotide deletion results in a novel null allele, HLA‐C*03:560N.
Identification of a novel allele HLA‐C*03:560N by next‐generation sequencing in a hematopoietic stem cell recipient
A frameshift because of a single nucleotide deletion results in a novel null allele, HLA‐C*03:560N.
- 1 February 2018
- Vol. 26 (1) , 32-41
[Relationship between High-Resolution HLA-A,-B,-DRB1 Alleles and Haplotype Polymorphisms with Myeloid Leukemia of Han People in North China].
To investigate the potential relationship between the high-resolution HLA-A,-B,-DRB1 alleles and haplotype polymorphism with actute myeloid leukemia (AML) and chronic myeloid leukemia (CML) of Han people in North China. A total of 1241 healthy unrelated Han people's bone marrow donors in North China were used as a control group, 259 patients with myeloid leukemia were genotyped at high-resolution level by means of PCR-SBT, -SSO and -SSP typing methods for HLA-A,-B,-DRB1 loci. The frequencies of HLA allele and haplotype were calculated by software Arleguin 3.5.2. The different distribution of genes and haplotypes was analyzed by case control study, and the odd ratio (OR) of leukemia was also calculated. The structural difference of HLA alleles was analyzed 111by HLA three-dimensional structure modeling and software Swiss-PdbViewer v4.1. χ2 test and correction showed that an increased frequency of A*02:07 (8.47% vs 5.28%, P' =0.013), A*29:01 (1.85% vs 0.68%, P=0.044), B*07:02 (5.29% vs 3.10%, P=0.029), B*07:05:01G (1.85% vs 0.68%, P=0.044) and B*35:02 (1.06% vs 0.20%, P=0.023) were found in AML patients (n=189) as compared with controls, respectively; whereas A*02:03 was less frequent in AML as compared with controls (0.79% vs 3.10%, P=0.011). The frequency of B*46:01 was lower in CML patients (n=70) as compared with controls (2.86% vs 7.82%, P=0.031). However, the above-mentioned discrepancies were not statistically significant by Bonferroni correction. Through Fisher exact test and Bonferroni correction, the frequency of DRB1*11:28 and its haplotype A*24:02-B*15:01-DRB1*11:28 in CML group were very significantly higher than in controls (1.43% vs 0.00%, Pc=0.015; 1.43% vs 0.00%, P=0.003). Three-dimensional structure modeling of DRB1*11:28 and DRB1*11:01 presented significant structure differentiation (RMSD=0.09 nm) in peptide binding region of the backbone calculated by Swiss-PdbViewer v4.1. The haplotype A*03:01-B*50:01-DRB1*07:01 in AML and A*11:01-B*40:06-DRB1*09:01 in CML patients were significantly higher than that in controls (1.06% vs 0.00%, Pc=0.000; 2.86% vs 0.07%, Pc=0.000), and positively correlated with leukemia (OR=59.66, 95% CI=3.21-1110.39; OR=42.91, 95% CI=7.07-260.32). The relationship of HLA-A,-B,-DRB1 alleles and haplotype polymorphism with leukemia at high-resolution level were obtained and unique in north Chinese Han population. AML and CML patients in Northern Han people carry particular susceptible haplotypes. DRB1*11:28, which might not actively present bcr-abl peptide to CD4+ T cells, and is a susceptibile gene for CML patients of Northern Han people, especially in Shaanxi Province (OR=89.62, 95% CI=4.28-1875.87), as well as correlated with its particular haplotype.
- 1 February 2018
- Vol. 26 (1) , 32-41
[Relationship between High-Resolution HLA-A,-B,-DRB1 Alleles and Haplotype Polymorphisms with Myeloid Leukemia of Han People in North China].
To investigate the potential relationship between the high-resolution HLA-A,-B,-DRB1 alleles and haplotype polymorphism with actute myeloid leukemia (AML) and chronic myeloid leukemia (CML) of Han people in North China. A total of 1241 healthy unrelated Han people's bone marrow donors in North China were used as a control group, 259 patients with myeloid leukemia were genotyped at high-resolution level by means of PCR-SBT, -SSO and -SSP typing methods for HLA-A,-B,-DRB1 loci. The frequencies of HLA allele and haplotype were calculated by software Arleguin 3.5.2. The different distribution of genes and haplotypes was analyzed by case control study, and the odd ratio (OR) of leukemia was also calculated. The structural difference of HLA alleles was analyzed 111by HLA three-dimensional structure modeling and software Swiss-PdbViewer v4.1. χ2 test and correction showed that an increased frequency of A*02:07 (8.47% vs 5.28%, P' =0.013), A*29:01 (1.85% vs 0.68%, P=0.044), B*07:02 (5.29% vs 3.10%, P=0.029), B*07:05:01G (1.85% vs 0.68%, P=0.044) and B*35:02 (1.06% vs 0.20%, P=0.023) were found in AML patients (n=189) as compared with controls, respectively; whereas A*02:03 was less frequent in AML as compared with controls (0.79% vs 3.10%, P=0.011). The frequency of B*46:01 was lower in CML patients (n=70) as compared with controls (2.86% vs 7.82%, P=0.031). However, the above-mentioned discrepancies were not statistically significant by Bonferroni correction. Through Fisher exact test and Bonferroni correction, the frequency of DRB1*11:28 and its haplotype A*24:02-B*15:01-DRB1*11:28 in CML group were very significantly higher than in controls (1.43% vs 0.00%, Pc=0.015; 1.43% vs 0.00%, P=0.003). Three-dimensional structure modeling of DRB1*11:28 and DRB1*11:01 presented significant structure differentiation (RMSD=0.09 nm) in peptide binding region of the backbone calculated by Swiss-PdbViewer v4.1. The haplotype A*03:01-B*50:01-DRB1*07:01 in AML and A*11:01-B*40:06-DRB1*09:01 in CML patients were significantly higher than that in controls (1.06% vs 0.00%, Pc=0.000; 2.86% vs 0.07%, Pc=0.000), and positively correlated with leukemia (OR=59.66, 95% CI=3.21-1110.39; OR=42.91, 95% CI=7.07-260.32). The relationship of HLA-A,-B,-DRB1 alleles and haplotype polymorphism with leukemia at high-resolution level were obtained and unique in north Chinese Han population. AML and CML patients in Northern Han people carry particular susceptible haplotypes. DRB1*11:28, which might not actively present bcr-abl peptide to CD4+ T cells, and is a susceptibile gene for CML patients of Northern Han people, especially in Shaanxi Province (OR=89.62, 95% CI=4.28-1875.87), as well as correlated with its particular haplotype.
- 1 September 2017
- Published by Wiley in The Journal of Gene Medicine
- Vol. 19 (9-10)
Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population
Background: Occult hepatitis B virus (HBV) infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBV surface antigen (HBsAg) negative patients with or without serologic markers of previous HBV exposure. Because the human leukocyte antigen (HLA) system is an integral component of the immune response, we hypothesized that the highly polymorphic HLA genes were the key determinants of HBV persistence and clearance. The present study aimed to calculate the allelic frequency of HLA loci and investigate the association between HLA alleles and the outcome of OBI in Shaanxi Han population in the northwest of China.Methods: We conducted a case–control study between 107 OBI subjects and 280 healthy control individuals from blood donors of Shaanxi Blood Center. Five HLA loci, including HLA‐A,‐B,‐C,‐DRB1 and ‐DQB1, were selected and further genotyped using a polymerase chain reaction sequence‐based typing (SBT) method.Results: Using the chi‐squared test, we found that the allele frequencies of HLA‐B*44:03 [odds ratios (OR) = 2.146, 95% confidence interval (CI) = 1.070–4.306, p = 0.028]; C*07:01 (OR = 4.693, CI = 1.822–12.086, p = 0.000); DQB1*02:02 (OR = 1.919, CI = 1.188–3.101, p = 0.007); and DRB1*07:01 (OR = 2.012, CI = 1.303–3.107, p = 0.001) were markedly higher in the OBI group compared to the healthy control group. The allele frequencies of HLA‐DRB1*08:03 (OR = 0.395, CI = 0.152–1.027, p = 0.049); DRB1*15:01 (OR = 0.495, CI = 0.261–0.940, p = 0.029); and DQB1*06:02 (OR = 0.500, CI = 0.249–1.005, p = 0.048) were obviously lower in the OBI group compared to the healthy control group. These data indicated that HLA‐B*44:03, C*07:01, DQB1*02:02 and DRB1*07:01 were related to OBI infection, whereas HLA‐DRB1*08:03, DRB1*15:01 and DQB1*06:02 alleles were associated with HBV DNA clearance in a Shaanxi Han population.Conclusions: The results of the present study suggest that host HLA gene is an important influencing factor for OBI pathogenesis.
- 1 September 2017
- Published by Wiley in The Journal of Gene Medicine
- Vol. 19 (9-10)
Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population
Background: Occult hepatitis B virus (HBV) infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBV surface antigen (HBsAg) negative patients with or without serologic markers of previous HBV exposure. Because the human leukocyte antigen (HLA) system is an integral component of the immune response, we hypothesized that the highly polymorphic HLA genes were the key determinants of HBV persistence and clearance. The present study aimed to calculate the allelic frequency of HLA loci and investigate the association between HLA alleles and the outcome of OBI in Shaanxi Han population in the northwest of China.Methods: We conducted a case–control study between 107 OBI subjects and 280 healthy control individuals from blood donors of Shaanxi Blood Center. Five HLA loci, including HLA‐A,‐B,‐C,‐DRB1 and ‐DQB1, were selected and further genotyped using a polymerase chain reaction sequence‐based typing (SBT) method.Results: Using the chi‐squared test, we found that the allele frequencies of HLA‐B*44:03 [odds ratios (OR) = 2.146, 95% confidence interval (CI) = 1.070–4.306, p = 0.028]; C*07:01 (OR = 4.693, CI = 1.822–12.086, p = 0.000); DQB1*02:02 (OR = 1.919, CI = 1.188–3.101, p = 0.007); and DRB1*07:01 (OR = 2.012, CI = 1.303–3.107, p = 0.001) were markedly higher in the OBI group compared to the healthy control group. The allele frequencies of HLA‐DRB1*08:03 (OR = 0.395, CI = 0.152–1.027, p = 0.049); DRB1*15:01 (OR = 0.495, CI = 0.261–0.940, p = 0.029); and DQB1*06:02 (OR = 0.500, CI = 0.249–1.005, p = 0.048) were obviously lower in the OBI group compared to the healthy control group. These data indicated that HLA‐B*44:03, C*07:01, DQB1*02:02 and DRB1*07:01 were related to OBI infection, whereas HLA‐DRB1*08:03, DRB1*15:01 and DQB1*06:02 alleles were associated with HBV DNA clearance in a Shaanxi Han population.Conclusions: The results of the present study suggest that host HLA gene is an important influencing factor for OBI pathogenesis.
- 10 April 2014
- Published by Wiley in Electrophoresis
- Vol. 35 (14) , 2001-2007
Diversity study of 12 X‐chromosomal STR loci in Hui ethnic from China
X‐chromosomal STRs (X‐STRs) have been used as complements of autosomal STR application in recent years. In this work, we present population genetic data of 12 X‐STRs including DXS101, DXS10159, DXS10162, DXS10164, DXS6789, DXS7133, DXS7423, DXS7424, DXS8378, DXS981, GATA165B12, and GATA31E08 loci in a sample of 231 unrelated healthy individuals from the Hui ethnic group in Ningxia Hui Autonomous Region, China. Allelic frequencies of the 12 X‐STR loci and haplotypic frequencies of the reported linkage groups (DXS7424‐DXS101 and DXS10159‐DXS10164‐DXS10162) were investigated in the group, respectively. No STR loci showed significant deviations from the Hardy–Weinberg equilibriums and no linkage disequilibriums of pairwise loci were found after Bonferroni correction, respectively. A combined power of discrimination in female individuals was 0.999999999985 and that in male individuals was 0.99999967, respectively. The combined mean exclusion chance in deficiency cases, normal trios and duo cases were 0.999934, 0.995754, and 0.999796, respectively. Significant differences were observed from 0 to 8 loci, when making comparisons between the data of Hui ethnic group and previously reported data from other 16 populations. The results indicated the new panel of 12 X‐STR loci might be useful for forensic science application.
- 10 April 2014
- Published by Wiley in Electrophoresis
- Vol. 35 (14) , 2001-2007
Diversity study of 12 X‐chromosomal STR loci in Hui ethnic from China
X‐chromosomal STRs (X‐STRs) have been used as complements of autosomal STR application in recent years. In this work, we present population genetic data of 12 X‐STRs including DXS101, DXS10159, DXS10162, DXS10164, DXS6789, DXS7133, DXS7423, DXS7424, DXS8378, DXS981, GATA165B12, and GATA31E08 loci in a sample of 231 unrelated healthy individuals from the Hui ethnic group in Ningxia Hui Autonomous Region, China. Allelic frequencies of the 12 X‐STR loci and haplotypic frequencies of the reported linkage groups (DXS7424‐DXS101 and DXS10159‐DXS10164‐DXS10162) were investigated in the group, respectively. No STR loci showed significant deviations from the Hardy–Weinberg equilibriums and no linkage disequilibriums of pairwise loci were found after Bonferroni correction, respectively. A combined power of discrimination in female individuals was 0.999999999985 and that in male individuals was 0.99999967, respectively. The combined mean exclusion chance in deficiency cases, normal trios and duo cases were 0.999934, 0.995754, and 0.999796, respectively. Significant differences were observed from 0 to 8 loci, when making comparisons between the data of Hui ethnic group and previously reported data from other 16 populations. The results indicated the new panel of 12 X‐STR loci might be useful for forensic science application.
- 1 December 2013
- Vol. 21 (6) , 1602-5
[Identification and analysis of the rare HLA-A/B/DRB1 allele genes of 10165 bone marrow registry donors in Shaanxi region].
This study was purposed to analyze the detected status of rare alleles from HLA-A/B/DRB1 typing of 10165 unrelated hematopoietic stem cell donors in Shaanxi region during 2009-2012. The rare allele distributions of HLA-A/B/DRB1 gene typing of 10165 unrelated-donors from Shaanxi sub-registry of Chinese National Marrow Donor Project (CMDP) were detected and analyzed by PCR-SBT. The results showed that there were 40 rare alleles from 48 donors identified by PCR-SBT in 10165 unrelated-donors of Shaanxi sub-registry. Among them, 10 rare alleles of A*02:04, B*07:10, B*27:09, B*35:11, B*44:29, DRB1*03:04, DRB1*08:18, DRB1*13:05, DRB1*13:14 and DRB1*14:11 from 15 donors were not included in the common alleles and well documented alleles (CWD) of China, but were included in the CWD of American Society for Histocompatibility and Immunogenetics (ASHI). The alleles of A*68:24, B*35:11, B*44:29, DRB1*03:04, DRB1*08:18 and DRB1*13:05 were confirmed in more than two samples. There were totally 21 novel HLA alleles identified by our laboratory and officially assigned by the WHO Nomenclature Committee from 2005 to 2012, and some of them were also detected from multiple donors in other HLA typing laboratories of China. Now the novel alleles of HLA-A*02:90, HLA-B*48:14 and HLA-DRB1*01:14 were added into the Chinese CWD list. It is concluded that to ensure the polymorphism integrity and accurate population distribution of HLA genes and its constant accumulations on CMDP, it is necessary to recognize and submit timely the potential novel alleles in our practical work, as well as to record and statistics the identified rare alleles, which can provide the basis for the modification of Chinese CWD. When CWD list is referred, it should be careful for ambiguous results containing the identified rare alleles in order to avoid the occurrence of false or undiscovered detection, and ensure that the patients carrying rare alleles could find a matching donor with the maximum opportunity.
- 1 December 2013
- Vol. 21 (6) , 1602-5
[Identification and analysis of the rare HLA-A/B/DRB1 allele genes of 10165 bone marrow registry donors in Shaanxi region].
This study was purposed to analyze the detected status of rare alleles from HLA-A/B/DRB1 typing of 10165 unrelated hematopoietic stem cell donors in Shaanxi region during 2009-2012. The rare allele distributions of HLA-A/B/DRB1 gene typing of 10165 unrelated-donors from Shaanxi sub-registry of Chinese National Marrow Donor Project (CMDP) were detected and analyzed by PCR-SBT. The results showed that there were 40 rare alleles from 48 donors identified by PCR-SBT in 10165 unrelated-donors of Shaanxi sub-registry. Among them, 10 rare alleles of A*02:04, B*07:10, B*27:09, B*35:11, B*44:29, DRB1*03:04, DRB1*08:18, DRB1*13:05, DRB1*13:14 and DRB1*14:11 from 15 donors were not included in the common alleles and well documented alleles (CWD) of China, but were included in the CWD of American Society for Histocompatibility and Immunogenetics (ASHI). The alleles of A*68:24, B*35:11, B*44:29, DRB1*03:04, DRB1*08:18 and DRB1*13:05 were confirmed in more than two samples. There were totally 21 novel HLA alleles identified by our laboratory and officially assigned by the WHO Nomenclature Committee from 2005 to 2012, and some of them were also detected from multiple donors in other HLA typing laboratories of China. Now the novel alleles of HLA-A*02:90, HLA-B*48:14 and HLA-DRB1*01:14 were added into the Chinese CWD list. It is concluded that to ensure the polymorphism integrity and accurate population distribution of HLA genes and its constant accumulations on CMDP, it is necessary to recognize and submit timely the potential novel alleles in our practical work, as well as to record and statistics the identified rare alleles, which can provide the basis for the modification of Chinese CWD. When CWD list is referred, it should be careful for ambiguous results containing the identified rare alleles in order to avoid the occurrence of false or undiscovered detection, and ensure that the patients carrying rare alleles could find a matching donor with the maximum opportunity.